Public Health

With President Trump and some Republican governors pushing to restart the nation’s economy, most of the public (80%) supports strict shelter-in-place policies to limit the coronavirus’ spread compared to just one in five (19%) who say these measures pose unnecessary burdens and cause more harm than good, the latest KFF…

This poll examines the public’s stance on the coronavirus outbreak and the social distancing and shelter-in-place restrictions as well as the public’s willingness to download apps to their phones to help public health officials with contact tracing,.

This analysis examines monkeypox (MPX) cases and vaccinations by race/ethnicity based on national data obtained from the Centers for Disease Control and Prevention (CDC). We find that while the current MPX outbreak in U.S. appears to be slowing down, disparities persist among Black and Hispanic people.

Rates of self-reported long COVID are one-quarter to one-third higher among adults who are female, transgender, Hispanic, and without a high-school degree than among all adults, according to federal survey data. In this policy watch, we consider whether long COVID could exacerbate existing disparities in health and employment.

According to a new KFF analysis assessing monkeypox (MPX) vaccine eligibility across the United States, people who are exposed or presumed exposed to MPX are generally eligible to get a vaccine across the country. However, eligibility varies across the United States for certain workers, including laboratory staff and others who…

This analysis examines jurisdictional approaches to eligibility for monkeypox (MPX) vaccine. Overall, almost all jurisdictions have, at minimum, adopted the current approach laid out by the CDC. However, there is substantial variation in how eligibility is defined. Additionally, several jurisdictions lack clear criteria or information on who is eligible or where to get vaccinated. This may impact on who gets vaccinated, lead to geographic disparities, and raises potentially equity challenges.

Long COVID has been described as our “next national health disaster” and the “pandemic after the pandemic,” but we know little about how many people are affected, how long it will last for those affected, and how it could change employment and health coverage landscapes. This policy watch reviews what we know and outlines key questions to watch for regarding employment and coverage outcomes. We continue to follow the research on who is most at risk of long COVID and whether there are interventions that can reduce its incidence, length, or severity.

This analysis examines monkeypox vaccine allocations and jurisdictional requests. It explores jurisdictional request rate (the number of vaccine does requested as a share of the jurisdiction’s allocation from HHS) for JYNNEOS, the preferred vaccine. Overall, while most jurisdictions have requested at least their full supply, some are well below that mark, raising questions about how quickly their at-risk populations can get protected.

This brief answers key questions about the U.S. monkeypox outbreak to date and identifies issues that may affect the response going forward.

This brief provides an explanation of Title 42 and its application in border regions, the impact of Title 42 on border expulsions and the health and well-being of migrants, and a discussion of the potential implications of lifting Title 42 for immigration and the health of migrants.